Global Stem Cell Therapy Market Analysis by Market Segmentation Based on Treatment, Based on application & by Region with Forecast 2017-2030

Global Stem Therapy Market Outlook

Cell therapy is the fourth and final therapeutic pillar of healthcare industry and the billion dollar global business with unlimited potential. The major targets include heart disease, diabetes, neurodegenerative diseases, musculoskeletal disorders, spinal cord injury, stroke, autoimmune diseases and major trauma. The CTI had global sales of USD 5.1 billion in 2014 and regenerative cell therapies acquired the major share among other segments. The stem cell therapy market is  growing at a CAGR of 10.05% through the forecast period (2017-2030). Recently, Fate Therapeutics, in collaboration with UC San Diego researcher, developed first off-the-shelf immunotherapy from human induced pluripotent stem cells that is now in clinical trials. Global stem cell banking market was valued USD 1.61 billion in 2016 and is anticipated to exhibit a CAGR of 17.56% over the forecast period.

Market Insights

Supportive stem cell research initiatives for personalized medicine- Major growth factor

High therapeutic potential of stem cells for treating genetic diseases is expected to propel the market growth. In the current scenario, immunosuppressive agents like steroids, induce long term side effects despite temporary improvements. Supportive stem cell research initiatives for personalized medicine  tends to accelerate the market growth.

North America estimated to consume largest market share of stem cell therapy

Regionally, North America is expected to consume the largest share of the stem cell therapy market due to technological advancements in healthcare setup, increasing awareness among the patient pool and public-private funding. Europe tends to be the second largest market for stem cell therapeutics owing to growing number of clinical trials and R&D grants.

Brain Repair By Own (Autologous) Cord Blood Stem Cells

Truly unique treatment for brain damage/cerebral palsy in newborn infants, a condition for which there is no treatment hitherto beyond supportive and occupational care is being developed. This autologous treatment is cord blood stem cell based therefore has no adverse effects.

Stem Cell Therapy Market Segmentation

Based on Treatment

• Allogeneic stem cell therapy
• Autologous stem cell therapy

Based on application:

• Gastro intestine diseases
• Metabolic diseases
• Immune system diseases
• Central Nervous System diseases
• Cardiovascular diseases
• Wounds and injuries
• Eye diseases
• Musculoskeletal disorders

COVID-19 impact on "Global Stem Cell Therapy Market"

The report analyses and includes complete detailed chapter of 50-70 pages about the short term & long terms impact of COVID-19 outbreak on each segment of "Global Stem Cell Therapy Market" along with government measures to support the sector. It also showcases the current market landscape during COVID, impact of the virus on leading companies, expected demand schedule and supply chain in the industry and other various major factors. This will help you identify those companies that may benefit from this pandemic as well as those that will lose out.

Key Market Players

There are thousands of research projects being worked on that involve stem cell technologies. Goldstein’s report covers the most promising of these. Companies profiled in this report consist of the players which have registered trials in Phase I through Phase III development.

1. Thermo Fischer Scientific
2. Qiagen NV
3. Sigma Aldrich Corp
4. Becton, Dickinson and Company
5. Cytori Therapeutics Inc.
6. Neuralstem Inc.
7. Aastrom Biotechnologies Inc.
8. Mesoblast Ltd.,
9. Roslin Cells,
10. Regeneus Ltd,
11. ReNeuron Group plc
12. International Stem Cell Corporation
13. NeoStem
14. Pharmicell
15. Pluristem
16. ReNeuron
17. SanBio
18. StemCells
19. Stemedica Cell
20. Stempeutics
21. Targazyme
22. TiGenix
23. ViaCyte
24. Advanced Cell Technology
25. Anterogen
26. Antria
27. apceth
28. Arteriocyte
29. Athersys
30. Baxter
31. BioCardia
32. Bioheart
33. BrainStorm Cell
34. Capricor
35. Celgene
36. Cytomedix
37. Gamida Cell
38. GlaxoSmithKline
39. ISCO
40. Intrexon
41. ISTO
42. Medipost

Scope of this Market Report on Stem Cell Therapy

•Detailed quantitative analysis of the current and future trends from 2017 to 2030, which helps to identify the prevailing market opportunities. The report estimates the opportunity by for novel technologies through an assessment of current products, pipeline, cost trends and regulation. Bottom-up and Top-Down analysis was used to determine market size and market forecasts.

•Comprehensive analysis of factors instrumental in changing the market scenario, rising prospective opportunities, market shares, core competencies in terms of market development, growth strategies and identification of key players that tends to influence the market on a global and regional scale

•Assessment of Market definition along with the identification of key drivers, restraints opportunities and challenges for this market during the forecast period

•Complete analysis of micro-markets with respect to individual growth trends, prospects, and contributions to the overall Stem Cell Therapeutics Solutions market

•Stem Cell Therapeutics market analysis and comprehensive segmentation with respect to the Application, End users, Treatment, and geography to assist in strategic business planning

•Stem Cell Therapeutics market analysis and forecast for five major geographies-North America, Europe, Asia Pacific, Middle East & Africa, Latin America, and their key regions.

Click here to get market research report sample that will help you get a detailed overview.